XML 52 R39.htm IDEA: XBRL DOCUMENT v3.10.0.1
Revenue recognition (Tables)
12 Months Ended
Dec. 31, 2018
Revenue from Contract with Customer [Abstract]  
Contract liabilities, rollforward and revenue recognition
The following table presents changes in the Company’s contract liabilities from December 31, 2017 to December 31, 2018:
 
 
Balance as of
December 31,
2017
 
Additions
 
Deductions
 
ASC 606 Adjustment
 
Balance as of
December 31,
2018
Deferred Revenue
 
$
11,891

 
$
6,417

 
$
(1,433
)
 
$
(3,937
)
 
$
12,938

The Company did not have any contract assets for the During the twelve months ended December 31, 2018.
During the twelve months ended December 31, 2018, the Company recognized revenue in the period from:
 
 
December 31,
2018
Amounts included in contract liabilities at the beginning of the period
 
$

Performance obligations satisfied in previous period
 

Performance obligations satisfied in current period
 
263,005

Total product revenue
 
$
263,005

Schedule of New Accounting Pronouncements and Changes in Accounting Principles
The impact of adoption using the modified retrospective method on the Company’s consolidated financial statements is as follows:

i.Consolidated balance sheets
 
 
Impact of changes in accounting policies
 
 
As reported December 31,
2018
 
Adjustments
 
As reported Balances without adoption of Topic 606
Assets
 
 

 
 
 
 
Current assets:
 
 

 
 
 
 
Cash and cash equivalents
 
$
169,498

 
$

 
$
169,498

Marketable securities
 
58,088

 

 
58,088

Trade receivables, net
 
67,907

 

 
67,907

Inventory
 
16,117

 
(84
)
 
16,033

Prepaid expenses and other current assets
 
9,247

 

 
9,247

Total current assets
 
320,857

 
(84
)
 
320,773

Fixed assets, net
 
12,694

 

 
12,694

Intangible assets, net
 
701,031

 

 
701,031

Goodwill
 
82,341

 

 
82,341

Deposits and other assets
 
2,299

 

 
2,299

Total assets
 
$
1,119,222

 
$
(84
)
 
$
1,119,138

Liabilities and stockholders’ equity
 
 

 
 
 
 
Current liabilities:
 
 

 
 
 
 
Accounts payable and accrued expenses
 
$
128,199

 
$
(2,120
)
 
$
126,079

Current portion of long-term debt
 
11,667

 

 
11,667

Deferred revenue
 
3,716

 
10,563

 
14,279

Other current liabilities
 
3,814

 

 
3,814

  Deferred consideration payable- current
 
19,400

 

 
19,400

Total current liabilities
 
166,796

 
8,443

 
175,239

Deferred revenue - long-term
 
9,722

 

 
9,722

Long-term debt
 
141,347

 

 
141,347

Contingent consideration payable
 
310,240

 

 
310,240

Deferred consideration payable - long-term
 
18,300

 

 
18,300

Deferred tax liability
 
122,032

 

 
122,032

Other long-term liabilities
 
58

 

 
58

Total liabilities
 
768,495

 
8,443

 
776,938

 
 
 
 
 
 
 
Stockholders’ equity:
 
 

 
 
 
 
Common stock
 
51

 

 
51

Additional paid-in capital
 
1,288,137

 

 
1,288,137

Accumulated other comprehensive income
 
1,462

 

 
1,462

Accumulated deficit
 
(938,923
)
 
(8,527
)
 
(947,450
)
Total stockholders’ equity
 
350,727

 
(8,527
)
 
342,200

Total liabilities and stockholders’ equity
 
$
1,119,222

 
$
(84
)
 
$
1,119,138


Consolidated statements of operations
 
 
Impact of changes in accounting policies
Twelve Months Ended
 
 
As reported for the period ended December 31,
2018
 
Adjustments
 
As reported Balances without adoption of Topic 606
Revenues:
 
 

 
 
 
 

Net product revenue
 
$
263,005

 
$
(5,177
)
 
$
257,828

Collaboration and grant revenue
 
1,729

 

 
1,729

Total revenues
 
264,734

 
(5,177
)
 
259,557

Operating expenses:
 
 

 
 
 
 

Cost of product sales, excluding amortization of acquired intangible asset
 
12,670

 
(84
)
 
12,586

Amortization of acquired intangible asset
 
22,877

 

 
22,877

Research and development
 
171,984

 

 
171,984

Selling, general and administrative
 
153,548

 

 
153,548

Change in the fair value of deferred and contingent consideration
 
19,340

 

 
19,340

Total operating expenses
 
380,419

 
(84
)
 
380,335

Loss from operations
 
(115,685
)
 
(5,093
)
 
(120,778
)
Interest expense, net
 
(12,554
)
 

 
(12,554
)
Other income, net
 
129

 

 
129

Loss before income tax expense
 
(128,110
)
 
(5,093
)
 
(133,203
)
Income tax benefit
 
29

 

 
29

Net loss attributable to common stockholders
 
$
(128,081
)
 
$
(5,093
)
 
$
(133,174
)
 
 
 
 
 
 
 

iii.Consolidated statements of comprehensive loss
 
 
Impact of changes in accounting policies
Twelve Months Ended
 
 
As reported for the period ended December 31,
2018
 
Adjustments
 
As reported Balances without adoption of Topic 606
Net loss
 
$
(128,081
)
 
$
(5,093
)
 
$
(133,174
)
Other comprehensive loss:
 
 

 
 
 
 

Unrealized gain on marketable securities, net of tax
 
9

 

 
9

Foreign currency translation loss
 
(2,516
)
 

 
(2,516
)
Comprehensive loss
 
$
(130,588
)
 
$
(5,093
)
 
$
(135,681
)

iv.Consolidated statements of cash flows
 
 
Impact of changes in accounting policies
 
 
As reported for the period ended December 31,
2018
 
Adjustments
 
Balances without adoption of Topic 606
Cash flows from operating activities
 
 

 
 
 
 

Net loss
 
$
(128,081
)
 
$
(5,093
)
 
$
(133,174
)
Adjustments to reconcile net loss to net cash used in operating activities:
 
 

 
 
 
 

Depreciation and amortization
 
26,087

 

 
26,087

Change in valuation of deferred and contingent consideration
 
19,340

 

 
19,340

Amortization of premiums on investments
 
(433
)
 

 
(433
)
Amortization of debt issuance costs
 
524

 

 
524

Share-based compensation expense
 
33,252

 

 
33,252

Non-cash interest expense
 
7,518

 

 
7,518

Disposal of asset
 
2

 

 
2

Unrealized foreign currency transaction (gains) losses, net
 
(59
)
 

 
(59
)
Changes in operating assets and liabilities:
 
 
 
 
 
0

Inventory, net
 
(5,823
)
 
(84
)
 
(5,907
)
Prepaid expenses and other current assets
 
(1,609
)
 

 
(1,609
)
Trade receivables, net
 
(29,589
)
 

 
(29,589
)
Deposits and other assets
 
(1,093
)
 

 
(1,093
)
Accounts payable and accrued expenses
 
43,877

 
(2,120
)
 
41,757

Other long-term liabilities
 
1,932

 

 
1,932

Deferred revenue
 
6,514

 
7,297

 
13,811

Net cash used in operating activities
 
(27,641
)
 

 
(27,641
)
Cash flows from investing activities
 
 

 
 
 
 

Purchases of fixed assets
 
(7,097
)
 

 
(7,097
)
Purchases of marketable securities
 
(68,614
)
 

 
(68,614
)
Sale & redemption of marketable securities
 
90,423

 

 
90,423

Acquisition of product rights
 
(8,433
)
 

 
(8,433
)
Business acquisition, net of cash acquired
 
(48,892
)
 

 
(48,892
)
Net cash used in investing activities
 
(42,613
)
 

 
(42,613
)
Cash flows from financing activities
 
 

 
 
 
 

Proceeds from exercise of options
 
10,868

 

 
10,868

Proceeds from shares issued under employee stock purchase plan
 
2,787

 

 
2,787

Net proceeds from public offerings
 
117,916

 

 
117,916

Net cash provided by financing activities
 
131,571

 

 
131,571

Effect of exchange rate changes on cash
 
(3,611
)
 

 
(3,611
)
Net increase in cash and cash equivalents
 
57,706

 

 
57,706

Cash and cash equivalents, beginning of period
 
111,792

 

 
111,792

Cash and cash equivalents, end of period
 
$
169,498

 
$

 
$
169,498